Introduction The impact of obstructive sleep apnoea (OSA) treatment with CPAP on weight is
not clear. This meta-analysis was designed to assess whether OSA treatment with CPAP …

Background CPAP reduces blood pressure (BP) in patients with symptomatic obstructive
sleep apnoea (OSA). Whether the same benefit is present in patients with minimally …

Background Obesity and obstructive sleep apnea tend to coexist and are associated with
inflammation, insulin resistance, dyslipidemia, and high blood pressure, but their causal …

Study Objective: To determine the impact of continuous positive airway pressure (CPAP) on
weight change in persons with obstructive sleep apnea (OSA). Design, Setting, and …

Study objectives: Obesity is an important risk factor for obstructive sleep apnea syndrome
(OSAS), and weight loss can reduce apnea severity or even lead to resolution in some …

Purpose To systematically evaluate the impact of diet, exercise and lifestyle modification
programmes on indices of obesity, Obstructive Sleep Apnoea (OSA) parameters and quality …

Rationale and objectives Impaired insulin sensitivity (ISx), increased visceral abdominal fat
(VAF) and liver fat are all central components of the metabolic syndrome and characteristics …

Study objective To synthesize evidence from available studies on the relative efficacies of
continuous positive airway pressure (CPAP), mandibular advancement device (MAD) …

Background: Obstructive sleep apnoea syndrome (OSAS) affects an estimated 2–4% of the
middle aged population. Meta-analyses of randomised controlled trials have shown that the …

Obstructive sleep apnoea is associated with increased blood pressure and other features of
the metabolic syndrome. The aim of the present study was to determine the relative …